KRTAP19-10P

Across TCGA pan-cancer cohorts, KRTAP19-10P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated KRTAP19-10P data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher KRTAP19-10P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated KRTAP19-10P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

KIRP, LUAD, and BLCA are the cancer types where KRTAP19-10P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	II,III,IV	0.161	0.771	.002	45	view →
LUAD	OS	Tertile	All	0.235	0.697	.010	36	view →
BLCA	DFS	Tertile	All	0.078	0.594	<.001	27	view →
KIRC	OS	Tertile	All	0.697	0.875	.011	24	view →
OV	DFS	Tertile	All	0.132	0.541	.001	18	view →
ESCA	OS	Tertile	III,IV	1.000	0.374	.043	12	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

KRTAP19-10P–KIRP (OS)

Open the KIRP breakdown →